Neurotoxin Versus Neuromodulation for the Treatment of Refractory Overactive Bladder Syndrome

Michael B. Chancellor ； Frank Costa ； Hann-Chorng Kuo

《慈濟醫學雜誌》 20卷2期 (2008/06) Pp. 109-111

並列摘要

Overactive bladder (OAB) is common and is estimated to affect 16.5% of the adult population. In patients refractory to pharmacotherapy, new treatment modalities, such as neuromodulation and botulinum toxin (BoNT), have had encouraging results. Neuromodulation has promising efficacious results in treating refractory OAB, urinary retention and bowel dysfunction, but the reoperation rate is relatively high, and the full mechanism of action of sacral nerve modulation is incompletely understood. BoNT is another potential alternative to surgical intervention for patients with refractory OAB, neurogenic detrusor overactivity and interstitial cystitis. BoNT-A injection in patients with idiopathic detrusor overactivity have reported increases in cystometric capacity, improved subjective symptoms and urodynamic parameters, and improved quality of life. BoNT injection offers an efficacious, minimally invasive alternative to sacral nerve modulation for the treatment of refractory OAB.

並列關鍵字

Detrusor overactivity ； Neuromodulation ； Neurotoxin ； Overactive bladder